PRWeek | Healthcare M&A in 2022: private equity has ‘huge interest’ in medcomms agencies
Dec 2021
Originally published by PRWeek on December 8, 2021.
James West, Director in Lincoln’s Healthcare Group discusses private equity firm’s interest in the medcomms space and the forecast for Healthcare M&A activity in 2022 .
Summary
-
James West, Director at Lincoln International's Healthcare Group speaks with PRWeek on Healthcare M&A activity in 2022.
- Sign up to receive Lincoln's perspectives
Contributor
Related Perspectives
In Vivo Pharma Intelligence | The Growth Path for Drug Discovery Partners
Originally published by In Vivo Pharma Intelligence on November 15, 2022 James West, Director in Lincoln’s Healthcare Group, explains the key trends and mergers and acquisitions (M&A) dynamics in the… Read More
Lincoln’s Latest
In Q3 2020, Lincoln International introduced Lincoln’s Latest video series. Experts from across industries, services and geographies, share perspectives on current trends, recent observations and future outlooks through this video… Read More
Surging Medical Inflation Fuels Continued Interest in Self-Funding and Cost Containment
During the past 18 months, inflation has accelerated to levels not seen since the early 1980s. The cost of energy, food and other staples has increased rapidly and is expected… Read More
Lincoln International Expands Presence to Southeast, Opening Miami and Atlanta Offices
Continued growth spurs openings in new geographies for both client coverage and talent acquisition Lincoln International announced today that it has expanded its U.S. footprint with the opening of offices… Read More
